相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Fragment tailoring strategy to design novel chemical entities as potential binders of novel corona virus main protease
Chinmayee Choudhury
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Fragment-based Discovery of Potential Anticancer Lead: Computational and in vitro Studies
Abdulmalek A. Balgoname et al.
CURRENT COMPUTER-AIDED DRUG DESIGN (2021)
Protein-ligand interaction-guided discovery of novel VEGFR-2 inhibitors
Yanmin Zhang et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2020)
Structural characterization of β-ketoacyl ACP synthase I bound to platencin and fragment screening molecules at two substrate binding sites
Edward I. Patterson et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2020)
Discovery of potential Toxoplasma gondii CDPK1 inhibitors with new scaffolds based on the combination of QSAR and scaffold-hopping method with in vitro validation
Pengyi Zhang et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2020)
Comprehensive and High-Throughput Exploration of Chemical Space Using Broadband19F NMR-Based Screening
Andreas Lingel et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Rapid Discovery of Aspartyl Protease Inhibitors Using an Anchoring Approach
Markella Konstantinidou et al.
CHEMMEDCHEM (2020)
In silico Strategies to Support Fragment-to-Lead Optimization in Drug Discovery
Lauro Ribeiro de Souza Neto et al.
FRONTIERS IN CHEMISTRY (2020)
Fragment-Based Design of Mycobacterium tuberculosis InhA Inhibitors
Mohamad Sabbah et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
A Proof-of-Concept Fragment Screening of a Hit-Validated 96-Compounds Library against Human Carbonic Anhydrase II
Steffen Gloeckner et al.
BIOMOLECULES (2020)
Fragment-Based Discovery of Non-bisphosphonate Binders of Trypanosoma brucei Farnesyl Pyrophosphate Synthase
Lena Munzker et al.
CHEMBIOCHEM (2020)
Fragment Screening Hit Draws Attention to a Novel Transient Pocket Adjacent to the Recognition Site of the tRNA-Modifying Enzyme TGT
Engi Hassaan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Identification of novel lysine demethylase 5-selective inhibitors by inhibitorbased fragment merging strategy
Yuka Miyake et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2019)
Fragment-based screening of programmed death ligand 1 (PD-L1)
Evan Perry et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
NAOMInext - Synthetically feasible fragment growing in a structure-based design context
Kai Sommer et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Fragment-based drug discovery of triazole inhibitors to block PDEδ-RAS protein-protein interaction
Danqi Chen et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
A bright future for fragment-based drug discovery: what does it hold?
Celien Jacquemard et al.
EXPERT OPINION ON DRUG DISCOVERY (2019)
Fragment-Based Discovery of a Qualified Hit Targeting the Latency-Associated Nuclear Antigen of the Oncogenic Kaposi's Sarcoma Associated Herpesvirus/Human Herpesvirus 8
Philine Kirsch et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Site-Directed Fragment-Based Screening for the Discovery of Protein-Protein Interaction Stabilizers
Eline Sijbesma et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
Discovery of potent SOS1 inhibitors that block RAS activation via disruption of the RAS-SOS1 interaction
Roman C. Hillig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Fragment-based Discovery of a Small-Molecule Protein Kinase C-iota Inhibitor Binding Post-kinase Domain Residues
Jacek Kwiatkowski et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Targeting the Bacterial Epitranscriptome for Antibiotic Development: Discovery of Novel tRNA-(N1G37) Methyltransferase (TrmD) Inhibitors
Wenhe Zhong et al.
ACS INFECTIOUS DISEASES (2019)
Embracing the Diversity of Halogen Bonding Motifs in Fragment-Based Drug Discovery-Construction of a Diversity-Optimized Halogen-Enriched Fragment Library
Johannes Heidrich et al.
FRONTIERS IN CHEMISTRY (2019)
Optimization of novel reversible Bruton's tyrosine kinase inhibitors identified using Tethering-fragment-based screens
Brian T. Hopkins et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2019)
Design, synthesis and biological evaluation of novel human monoamine oxidase B inhibitors based on a fragment in an X-ray crystal structure
Kai Cheng et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
A fragment-based approach towards the discovery of N-substituted tropinones as inhibitors of Mycobacterium tuberculosis transcriptional regulator EthR2
Hugues Prevet et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Design and Synthesis of Pyrrolidine-based Fragments That Sample Three-dimensional Molecular Space
Philip Garner et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Ranking Hits From Saturation Transfer Difference Nuclear Magnetic Resonance-Based Fragment Screening
Jonas Aretz et al.
FRONTIERS IN CHEMISTRY (2019)
A fragment-like approach to PYCR1 inhibition
Kirsty Milne et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Identification, synthesis and evaluation of CSF1R inhibitors using fragment based drug design
Pavan Kumar Machiraju et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY (2019)
19F-NMR in Target-based Drug Discovery
CongBao Kang
CURRENT MEDICINAL CHEMISTRY (2019)
Structure-Guided Discovery of a Selective Mcl-1 Inhibitor with Cellular Activity
Zoltan Szlavik et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Structural and Functional Analyses of an Allosteric EYA2 Phosphatase Inhibitor That Has On-Target Effects in Human Lung Cancer Cells
Jothi Anantharajan et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Structure-guided fragment-based drug discovery at the synchrotron: screening binding sites and correlations with hotspot mapping
Sherine E. Thomas et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES (2019)
Drugging an undruggable pocket on KRAS
Dirk Kessler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Establishing Drug Discovery and Identification of Hit Series for the Anti-apoptotic Proteins, Bcl-2 and Mcl-1
James B. Murray et al.
ACS OMEGA (2019)
Discovery of a novel 3,4-dimethylcinnoline carboxamide M4 positive allosteric modulator (PAM) chemotype via scaffold hopping
Kayla J. Temple et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Design of selective PI3Kδ inhibitors using an iterative scaffold-hopping workflow
Xavier Fradera et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Development of a Fragment-Based Screening Assay for the Focal Adhesion Targeting Domain Using SPR and NMR
Carlos Alvarado et al.
MOLECULES (2019)
Rapid generation of novel benzoic acid-based xanthine derivatives as highly potent, selective and long acting DPP-4 inhibitors: Scaffold-hopping and prodrug study
Qing Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
The Fragment-Based Development of a Benzofuran Hit as a New Class of Escherichia coli DsbA Inhibitors
Luke F. Duncan et al.
MOLECULES (2019)
Identification of the Binding Site of Apical Membrane Antigen 1 (AMA1) Inhibitors Using a Paramagnetic Probe
Mansura Akter et al.
CHEMMEDCHEM (2019)
Chemical Space Overlap with Critical Protein-Protein Interface Residues in Commercial and Specialized Small-Molecule Libraries
Yubing Si et al.
CHEMMEDCHEM (2019)
Applications of In-Cell NMR in Structural Biology and Drug Discovery
CongBao Kang
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Metal-Binding Pharmacophore Library Yields the Discovery of a Glyoxalase 1 Inhibitor
Christian Perez et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Tyrosyl phosphorylation of KRAS stalls GTPase cycle via alteration of switch I and II conformation
Yoshihito Kano et al.
NATURE COMMUNICATIONS (2019)
Development and validation of RdRp Screen, a crystallization screen for viral RNA-dependent RNA polymerises
Federica Riccio et al.
BIOLOGY OPEN (2019)
Rethinking Glioblastoma Therapy: MDA-9/Syntenin Targeted Small Molecule
Swadesh K. Das et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Fragment-Based Drug Discovery: Advancing Fragments in the Absence of Crystal Structures
Daniel A. Erlanson et al.
CELL CHEMICAL BIOLOGY (2019)
Agrochemical lead optimization by scaffold hopping
Clemens Lamberth
PEST MANAGEMENT SCIENCE (2018)
Computational Fragment-Based Drug Design: Current Trends, Strategies, and Applications
Yuemin Bian et al.
AAPS JOURNAL (2018)
Structural and ligand-binding analysis of the YAP-binding domain of transcription factor TEAD4
Yan Li et al.
BIOCHEMICAL JOURNAL (2018)
Fragment-Based Drug Discovery of Potent Protein Kinase C Iota Inhibitors
Jacek Kwiatkowski et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
NMR-Fragment Based Virtual Screening: A Brief Overview
Meenakshi Singh et al.
MOLECULES (2018)
Current NMR Techniques for Structure-Based Drug Discovery
Toshihiko Sugiki et al.
MOLECULES (2018)
Structural Insights into the Inhibition of Zika Virus NS2B-NS3 Protease by a Small-Molecule Inhibitor
Yan Li et al.
STRUCTURE (2018)
Target-Based Discovery of an Inhibitor of the Regulatory Phosphatase PPP1R15B
Agnieszka Krzyzosiak et al.
CELL (2018)
Evolution of In Silico Strategies for Protein-Protein Interaction Drug Discovery
Stephani Joy Y. Macalino et al.
MOLECULES (2018)
CellFy: A Cell-Based Fragment Screen against C-Type Lectins
Jessica Schulze et al.
ACS CHEMICAL BIOLOGY (2018)
Discovery of Novel Druggable Sites on Zika Virus NS3 Helicase Using X-ray Crystallography-Based Fragment Screening
Ali Munawar et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Recent Applications of Diversity-Oriented Synthesis Toward Novel, 3-Dimensional Fragment Collections
Sarah L. Kidd et al.
FRONTIERS IN CHEMISTRY (2018)
Current perspectives in fragment-based lead discovery (FBLD)
Bas Lamoree et al.
STRUCTURE-BASED DRUG DESIGN: INSIGHTS FROM ACADEMIA AND INDUSTRY (2017)
Stabilization of protein-protein interactions in drug discovery
Sebastian A. Andrei et al.
EXPERT OPINION ON DRUG DISCOVERY (2017)
Structural characterization of the linked NS2B-NS3 protease of Zika virus
Yan Li et al.
FEBS LETTERS (2017)
High-Confidence Protein-Ligand Complex Modeling by NMR-Guided Docking Enables Early Hit Optimization
Andrew Proudfoot et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2017)
Solution NMR Spectroscopy in Target-Based Drug Discovery
Yan Li et al.
MOLECULES (2017)
Structural basis of PROTAC cooperative recognition for selective protein degradation
Morgan S. Gadd et al.
NATURE CHEMICAL BIOLOGY (2017)
Structural Dynamics of Zika Virus NS2B-NS3 Protease Binding to Dipeptide Inhibitors
Yan Li et al.
STRUCTURE (2017)
19F-NMR-Based Dual-Site Reporter Assay for the Discovery and Distinction of Catalytic and Allosteric Kinase Inhibitors
Lukasz Skora et al.
ACS MEDICINAL CHEMISTRY LETTERS (2017)
STD-NMR experiments identify a structural motif with novel second-site activity against West Nile virus NS2B-NS3 protease
Tobias Schoene et al.
ANTIVIRAL RESEARCH (2017)
Drugging the 'undruggable' cancer targets
Chi V. Dang et al.
NATURE REVIEWS CANCER (2017)
Multivalent Small-Molecule Pan-RAS Inhibitors
Matthew E. Welsch et al.
CELL (2017)
A False-Positive Screening Hit in Fragment-Based Lead Discovery: Watch out for the Red Herring
Jonathan Cramer et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
Docking and Linking of Fragments To Discover Jumonji Histone Demethylase Inhibitors
Magdalena Korczynska et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Six Biophysical Screening Methods Miss a Large Proportion of Crystallographically Discovered Fragment Hits: A Case Study
Johannes Schiebel et al.
ACS CHEMICAL BIOLOGY (2016)
Fragment Linking and Optimization of Inhibitors of the Aspartic Protease Endothiapepsin: Fragment-Based Drug Design Facilitated by Dynamic Combinatorial Chemistry
Milon Mondal et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Chemical fragment arrays for rapid druggability assessment
J. Aretz et al.
CHEMICAL COMMUNICATIONS (2016)
Insights into Protein-Ligand Interactions: Mechanisms, Models, and Methods
Xing Du et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Applications of 19F-NMR in Fragment-Based Drug Discovery
Raymond S. Norton et al.
MOLECULES (2016)
Native Mass Spectrometry in Fragment-Based Drug Discovery
Liliana Pedro et al.
MOLECULES (2016)
Proteome-wide covalent ligand discovery in native biological systems
Keriann M. Backus et al.
NATURE (2016)
Protein-observed 19F-NMR for fragment screening, affinity quantification and druggability assessment
Clifford T. Gee et al.
NATURE PROTOCOLS (2016)
Twenty years on: the impact of fragments on drug discovery
Daniel A. Erlanson et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
The ways and means of fragment-based drug design
Bradley C. Doak et al.
PHARMACOLOGY & THERAPEUTICS (2016)
NMR in drug discovery: A practical guide to identification and validation of ligands interacting with biological macromolecules
Alvar D. Gossert et al.
PROGRESS IN NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY (2016)
High-Throughput Crystallography: Reliable and Efficient Identification of Fragment Hits
Johannes Schiebel et al.
STRUCTURE (2016)
Cell-based and virtual fragment screening for adrenergic α2C receptor agonists
Edit Szollosi et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Overcoming Chemical, Biological, and Computational Challenges in the Development of Inhibitors Targeting Protein-Protein Interactions
Luca Laraia et al.
CHEMISTRY & BIOLOGY (2015)
Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4
Jing Lu et al.
CHEMISTRY & BIOLOGY (2015)
Fragment-Based Drug Discovery and Molecular Docking in Drug Design
Tao Wang et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2015)
Application of Fragment-Based Drug Discovery against DNA GyraseB
Guo-Ying Chen et al.
CHEMPLUSCHEM (2015)
Small-Molecule Inhibitors of Protein-Protein Interactions: Progressing toward the Reality
Michelle R. Arkin et al.
CHEMISTRY & BIOLOGY (2014)
Off-Rate Screening (ORS) By Surface Plasmon Resonance. An Efficient Method to Kinetically Sample Hit to Lead Chemical Space from Unpurified Reaction Products
James B. Murray et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Biomimetic membrane platform containing hERG potassium channel and its application to drug screening
Ahu Arslan Yildiz et al.
ANALYST (2013)
Inhibitors of BACE for treating Alzheimer's disease: a fragment-based drug discovery story
Andrew Stamford et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2013)
Fragment-based drug discovery using NMR spectroscopy
Mary J. Harner et al.
JOURNAL OF BIOMOLECULAR NMR (2013)
Surface Plasmon Resonance Spectroscopy: A Versatile Technique in a Biochemist's Toolbox
Ray Bakhtiar
JOURNAL OF CHEMICAL EDUCATION (2013)
In Silico Fragment-Based Drug Discovery: Setup and Validation of a Fragment-to-Lead Computational Protocol Using S4MPLE
Laurent Hoffer et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2013)
Discovery of Potent Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods and Structure-Based Design
Anders Friberg et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Discovery of a Potent Inhibitor of Replication Protein A Protein- Protein Interactions Using a Fragment-Linking Approach
Andreas O. Frank et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Fragment-to-Hit-to-Lead Discovery of a Novel Pyridylurea Scaffold of ATP Competitive Dual Targeting Type II Topoisomerase Inhibiting Antibacterial Agents
Gregory S. Basarab et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Andrew J. Souers et al.
NATURE MEDICINE (2013)
The 'rule of three' for fragment-based drug discovery: where are we now?
Harren Jhoti et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Design and pharmacology of a highly specific dual FMS and KIT kinase inhibitor
Chao Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Using chemical shift perturbation to characterise ligand binding
Mike P. Williamson
PROGRESS IN NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY (2013)
Discovery of Protein-Protein Interaction Inhibitors of Replication Protein A
James D. Patrone et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
Application of Fragment Screening and Merging to the Discovery of Inhibitors of the Mycobacterium tuberculosis Cytochrome P450 CYP121
Sean A. Hudson et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
Fragment-Based Approaches in Drug Discovery and Chemical Biology
Duncan E. Scott et al.
BIOCHEMISTRY (2012)
Experimental and Computational Active Site Mapping as a Starting Point to Fragment-Based Lead Discovery
Juergen Behnen et al.
CHEMMEDCHEM (2012)
Vemurafenib: the first drug approved for BRAF-mutant cancer
Gideon Bollag et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Fragment Screening Using Capillary Electrophoresis (CEfrag) for Hit Identification of Heat Shock Protein 90 ATPase Inhibitors
Carol Austin et al.
JOURNAL OF BIOMOLECULAR SCREENING (2012)
Weak affinity chromatography as a new approach for fragment screening in drug discovery
Minh-Dao Duong-Thi et al.
ANALYTICAL BIOCHEMISTRY (2011)
Saturation-Transfer Difference (STD) NMR: A Simple and Fast Method for Ligand Screening and Characterization of Protein Binding
Aldino Viegas et al.
JOURNAL OF CHEMICAL EDUCATION (2011)
Crystal Structures of ABL-Related Gene (ABL2) in Complex with Imatinib, Tozasertib (VX-680), and a Type I Inhibitor of the Triazole Carbothioamide Class
Eidarus Salah et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Compound Design by Fragment-Linking
Osamu Ichihara et al.
MOLECULAR INFORMATICS (2011)
An NMR study of the N-terminal domain of wild-type hERG and a T65P trafficking deficient hERG mutant
Shovanlal Gayen et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2011)
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
Gideon Bollag et al.
NATURE (2010)
Fragment Screening by Surface Plasmon Resonance
Iva Navratilova et al.
ACS MEDICINAL CHEMISTRY LETTERS (2010)
Docking, virtual high throughput screening and in silico fragment-based drug design
Vincent Zoete et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
The rise of fragment-based drug discovery
Christopher W. Murray et al.
NATURE CHEMISTRY (2009)
Phosphorus NMR spectroscopy as a versatile tool for compound library screening
Florian Manzenrieder et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2008)
Overcoming the challenges of membrane protein crystallography
Elisabeth P. Carpenter et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2008)
Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity
James Tsai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Label-free primary screening and affinity ranking of fragment libraries using parallel analysis of protein panels
Markku D. Hamalainen et al.
JOURNAL OF BIOMOLECULAR SCREENING (2008)
Structure-based maximal affinity model predicts small-molecule druggability
Alan C. Cheng et al.
NATURE BIOTECHNOLOGY (2007)
The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability
Frank H. Niesen et al.
NATURE PROTOCOLS (2007)
Fragment-based lead discovery: a chemical update
Daniel A. Erlanson
CURRENT OPINION IN BIOTECHNOLOGY (2006)
SAR by ILOEs: An NMIR-based approach to reverse chemical genetics
B Becattini et al.
CHEMISTRY-A EUROPEAN JOURNAL (2006)
Discovery of a potent inhibitor of the antiapoptotic protein Bcl-xL from NMR and parallel synthesis
AM Petros et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Druggability indices for protein targets derived from NMR-based screening data
PJ Hajduk et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
TINS, target immobilized NMR screening: An efficient and sensitive method for ligand discovery
S Vanwetswinkel et al.
CHEMISTRY & BIOLOGY (2005)
Fragment-based lead discovery using X-ray crystallography
MJ Hartshorn et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Fragment-based drug discovery
DA Erlanson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
WaterLOGSY as a method for primary NMR screening: Practical aspects and range of applicability
C Dalvit et al.
JOURNAL OF BIOMOLECULAR NMR (2001)
NMR-based screening of proteins containing 13C-labeled methyl groups
PJ Hajduk et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2000)
分享论文
